I think SRX was much more difficult to hold after the trials failed than AXP. SRX was a product issue; it just didn't do what we all though it would do. AXP appears to be a sales issue, although what's driving it is still a bit of mystery.
That's why I'm more confident that a buyer will come along than I was with SRX after the trials failed.
All that being said, I'm happy I got out of this at 70c a few months ago.
AXP Price at posting:
18.0¢ Sentiment: Hold Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)